TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
Bladder, |
5637 |
|
|
|
TumCD↑, Apoptosis↑, TumCMig↓, TumCP↓,
| - |
vitro+vivo, |
Bladder, |
NA |
|
|
|
tumCV↓, TumCP↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, EMT↓, TumMeta↓, p65↓, p‑p65↓, IKKα↓, NF-kB↑, ROS↑, NRF2↓, HO-1↓, SOD2↓, GPx1↓, Bax:Bcl2↑, TumVol↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCMig↓, Casp↑, TumAuto↑, LC3B-II↑, p‑AMPK↑, mTOR↓, BMI1↓, ROS↑, eff↓,
| - |
in-vivo, |
RCC, |
A498 |
|
|
|
- |
in-vitro, |
RCC, |
T24/HTB-9 |
|
|
|
- |
NA, |
Bladder, |
5637 |
|
|
|
TRPV1↑, TumCP↓, Casp↑, Apoptosis↑, SIRT1↓, MMP2↓, MMP9↓, TumCMig↓, TumCCA↑, ROS↑, DNAdam↑, PD-L1↑, eff↓,
| - |
vitro+vivo, |
Bladder, |
5637 |
|
|
|
- |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
antiOx↑, Inflam↓, AntiCan↓, TRPV1↑, TumCP↓, TumCCA↑, ROS↑, FOXO3↑, TumCMig↓,
TumCP↓, TumCCA↑, selectivity↑, CSCs↓, SUV39H↓, GATA3↓, STAT3↓, TumCG↓, OS↑,
| - |
in-vitro, |
Bladder, |
RT112 |
|
|
|
- |
in-vitro, |
Bladder, |
UMUC3 |
|
|
|
Apoptosis↑, TumCG↓, TumCP↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
P53↑, NF-kB↓, TumCP↓, Apoptosis↑, TumCCA↑, P21↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK4↓, CDK2↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vivo, |
Bladder, |
NA |
|
|
|
TumCP↓, TumCCA↑, TumCMig↓, TumCI↓, ROS↑, Slug↓, β-catenin/ZEB1↓, Zeb1↓, N-cadherin↓, F-actin↓, GSH↓, EMT↓, CLDN1↓, ZO-1↓,
| - |
in-vitro, |
Bladder, |
RT112 |
|
|
|
selectivity↑, TumCP↓, Glycolysis↓, Hif1a↓,
| - |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCI↓, Casp↑, ROS↑, PD-L1↓, EMT↓, MMP↓, eff↓,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
253J |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
TumCP↓, Apoptosis↑, ER Stress↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp7↑, cl‑PARP↑, Cyt‑c↑, PERK↑, IRE1↑, ATF6↑, p‑eIF2α↑, ATF4↑, GRP78/BiP↑, CHOP/DDIT3↑,
Showing Research Papers: 1 to 12 of 12
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 12
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
SUV39H↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, GPx1↓, 1, GSH↓, 1, HO-1↓, 1, NRF2↓, 1, ROS↑, 6, SOD2↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
p‑AMPK↑, 1, Glycolysis↓, 1, SIRT1↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 5, Bak↑, 1, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp↑, 3, cl‑Casp3↑, 1, cl‑Casp7↑, 1, cl‑Casp8↑, 1, Cyt‑c↑, 1, p27/CDKN1B↑, 1, TRPV1↑, 2, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
ATF6↑, 1, CHOP/DDIT3↑, 1, p‑eIF2α↑, 1, ER Stress↑, 1, GRP78/BiP↑, 1, IRE1↑, 1, PERK↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3B-II↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 2, CDK4↓, 1, cycA1/CCNA1↓, 2, cycD1/CCND1↓, 2, P21↑, 2, TumCCA↑, 6,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
BMI1↓, 1, CSCs↓, 1, EMT↓, 3, FOXO3↑, 1, GATA3↓, 1, mTOR↓, 1, STAT3↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
CLDN1↓, 1, F-actin↓, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, Slug↓, 1, TumCI↓, 2, TumCMig↓, 5, TumCP↓, 12, TumMeta↓, 1, Zeb1↓, 1, ZO-1↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
ATF4↑, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IKKα↓, 1, Inflam↓, 1, NF-kB↓, 1, NF-kB↑, 1, p65↓, 1, p‑p65↓, 1, PD-L1↓, 1, PD-L1↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 3, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
PD-L1↓, 1, PD-L1↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↓, 1, OS↑, 1, TumVol↓, 1,
Total Targets: 83
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page